Tentt

Ouro Medicines Acquired by Gilead Sciences — Healthcare M&A

Announced
HealthcareOther

Deal Summary

Gilead Sciences agreed to acquire Ouro Medicines to advance a first-in-class T cell engager program for autoimmune diseases.

Key Details

Transaction
Gilead Sciences acquires Ouro Medicines

Source

Read full article on news.google.com

via GN - entered into definitive agreement · March 23, 2026

Related Deals